,

Of course, pharmaceutical companies are not completely right. Some pharmaceutical giants deliberately drive up drug prices, making these drugs too expensive for many patients to afford. This in itself is a kind of cruel exploitation. To a certain extent, these countries and regions adopt this method as a last resort confrontation, but this confrontation method is relatively controversial.

It’s really hard to say whether Wu Hao’s smart bionic electronic prosthetic limbs, medical smart mechanical exoskeleton, smart bionic electronic prosthetic eye, these medical devices are expensive or not.

Because if compared with the price and performance of similar products at home and abroad, the prices of their products are really too cheap. And it's still cheaper than similar products, and the performance is much, much higher.

It is said that the majority of patients should be satisfied, but the fact is just the opposite. Many patients think that the price is still too expensive. There is no way that this group has a large number of people and there are all kinds of people. In addition, the income level of this group is generally low due to disability and inability to work, so it is difficult to bear the high price.

Even though the prices of these products are already very cheap, there are still many people who cannot afford them, and they still think that the prices are too expensive.

And for these patients, hundreds of thousands and hundreds of thousands of medical equipment are just one aspect, and the cost of the entire treatment is also a big part. Including related surgical transplant costs, conventional treatment costs, and follow-up rehabilitation training costs for these medical devices, etc., the sum of the odds and ends is also a huge number, which is not necessarily much cheaper than the price of medical devices.

This is why many of these disabled patients still cannot afford the cost in this regard.

So whether these medical devices can significantly reduce the cost and price, it is actually very difficult. Why do you say that, because these medical devices involve customization issues.

We are different from person to person. In addition to individual character and soul, there are great differences in body height, skin color, blood type, etc. For example, the limbs of different people are different in thickness and length, which also makes the smart bionic electronic prosthetics worn by patients sufficiently matched and consistent with the proportions of the limbs, so these limbs need to be specially customized. , the price is of course very expensive.

In addition to the thickness and length of the limbs, there are also the proportions of the various segments of the limbs. Some people's fingers may be longer, some people's fingers may be shorter, and people's skin colors are also different. Men's and women's hands are also very different. of. It is obviously not good to give a female patient a man's thick hand, or a male patient a woman's delicate hand.

These can’t be mass-produced, and can only be customized according to measurement data. The production process is complicated, and the price will rise.

Some people think whether it is possible to use centralized procurement. This method is actually operable to a certain extent, but it is also difficult. Because Wu Hao and the others set the cost price relatively low, there is not much room for concessions. Moreover, this thing itself is a high-end medical product, and it is basically impossible to join the medical insurance. It is also because of the high price, so if the centralized procurement cannot reach the quantity, naturally there is no room for maneuvering.

Of course, there are still some products that can be mass-produced, such as intelligent bionic electronic prosthetic eyes, which can be mass-produced. However, even if mass production is achieved, its price cannot be reduced much, because this is a high-end medical device product with a high price. Moreover, the related transplant surgery is also very complicated, and the operation fee will be very expensive, so the overall price will be more expensive.

However, compared to the price, smart bionic electronic prosthetic eyes can help blind patients regain their sight, which is unmatched by more money, so for these patients, as long as they can restore their health, it is worth spending more money .

And Wu Hao and the others are now opening up some product patent technologies to domestic and foreign medical device companies, not to say that they are free of charge, but charged. Besides, it is only part of the patented technology, and the core technology, including the core algorithm of the system, is still in their hands.

So even if these companies produce related smart medical device products, they are still under their control. And through the channels of local medical device companies in these countries and regions, their products can also enter the markets of these countries and regions, which creates conditions for Haoyu Medical to become a powerful international famous medical enterprise brand.

Wu Hao and their calculations, can't other companies understand it? No, they see very clearly. This is not a conspiracy, but a public conspiracy. In front of everyone, for these pharmaceutical companies, as long as they are profitable, why not do it.

Back at the press conference, Wu Hao stood on the stage and waited quietly for the cheers and applause from the audience to fade away. Then he continued to speak unhurriedly: "In addition to these external wearable smart bionic medical devices, UU reading www .uukanshu.com We have also made great breakthroughs in the field of human intelligent bionic electronic organs. At present, we have developed an intelligent bionic artificial heart that can perfectly simulate all functions of the human heart, and an intelligent bionic artificial kidney. A breakthrough intelligent bionic artificial liver.

That's right, we have conducted bionic research on the three most important organs and tissues in the human body, and have made great breakthroughs in key technologies.

Take our intelligent bionic artificial heart that has been put into clinical trials as an example. At present, our Phase II clinical trial has basically come to an end. From Phase I clinical trial to Phase II clinical trial, we have successfully treated nearly 500 patients with heart failure. And a patient with severe heart disease has completed a smart bionic artificial heart transplant.

At present, among the nearly 500 patients, except for a very small number of patients, the postoperative recovery effect is poor due to other diseases caused by long-term heart disease, and a few people died of complications. They are all in excellent condition and have basically reached the level of full recovery.

After these patients are transplanted with our smart bionic artificial heart, they can basically return to the normal level, and may even be better than normal people in some aspects.

Maybe ordinary people run for a while and their heart beats fast, which makes you have a very bad reaction. But on the side of the intelligent bionic artificial heart, these are not problems, so it can support the wearer to complete some more strenuous exercises.

Many of our patients have returned to normal life after surgery. They live, work and exercise like normal people. Some people have become well-known local athletes, and some even started to try some extreme sports.

Let's get to know this ordinary and special group through a short video. "